PL3122766T3 - Ulepszone wykrywanie i diagnostyka przeciwciał przeciwjądrowych dla układowych i nieukładowych zaburzeń autoimmunologicznych - Google Patents

Ulepszone wykrywanie i diagnostyka przeciwciał przeciwjądrowych dla układowych i nieukładowych zaburzeń autoimmunologicznych

Info

Publication number
PL3122766T3
PL3122766T3 PL15768594T PL15768594T PL3122766T3 PL 3122766 T3 PL3122766 T3 PL 3122766T3 PL 15768594 T PL15768594 T PL 15768594T PL 15768594 T PL15768594 T PL 15768594T PL 3122766 T3 PL3122766 T3 PL 3122766T3
Authority
PL
Poland
Prior art keywords
systemic
diagnostics
autoimmune disorders
antibody detection
improved anti
Prior art date
Application number
PL15768594T
Other languages
English (en)
Inventor
Lakshmanan Suresh
Kishore Malyavantham
Original Assignee
IMMCO Diagnostics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMCO Diagnostics, Inc. filed Critical IMMCO Diagnostics, Inc.
Publication of PL3122766T3 publication Critical patent/PL3122766T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PL15768594T 2014-03-24 2015-03-24 Ulepszone wykrywanie i diagnostyka przeciwciał przeciwjądrowych dla układowych i nieukładowych zaburzeń autoimmunologicznych PL3122766T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461969771P 2014-03-24 2014-03-24
EP15768594.2A EP3122766B1 (en) 2014-03-24 2015-03-24 Improved anti-nuclear antibody detection and diagnostics for systemic and non-systemic autoimmune disorders
PCT/US2015/022120 WO2015148431A1 (en) 2014-03-24 2015-03-24 Improved anti-nuclear antibody detection and diagnostics for systemic and non-systemic autoimmune disorders

Publications (1)

Publication Number Publication Date
PL3122766T3 true PL3122766T3 (pl) 2021-09-13

Family

ID=54196278

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15768594T PL3122766T3 (pl) 2014-03-24 2015-03-24 Ulepszone wykrywanie i diagnostyka przeciwciał przeciwjądrowych dla układowych i nieukładowych zaburzeń autoimmunologicznych

Country Status (10)

Country Link
US (2) US10451633B2 (pl)
EP (2) EP3122766B1 (pl)
CN (2) CN112964883A (pl)
AU (3) AU2015236327B2 (pl)
CA (1) CA2942347C (pl)
ES (1) ES2870592T3 (pl)
HU (1) HUE054419T2 (pl)
PL (1) PL3122766T3 (pl)
PT (1) PT3122766T (pl)
WO (1) WO2015148431A1 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012333134B2 (en) 2011-07-22 2017-05-25 John Paul Guilinger Evaluation and improvement of nuclease cleavage specificity
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9737604B2 (en) 2013-09-06 2017-08-22 President And Fellows Of Harvard College Use of cationic lipids to deliver CAS9
US9340800B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College Extended DNA-sensing GRNAS
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US9068179B1 (en) 2013-12-12 2015-06-30 President And Fellows Of Harvard College Methods for correcting presenilin point mutations
AU2015298571B2 (en) 2014-07-30 2020-09-03 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
CA3032699A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
WO2018031683A1 (en) 2016-08-09 2018-02-15 President And Fellows Of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
EP3526320A1 (en) 2016-10-14 2019-08-21 President and Fellows of Harvard College Aav delivery of nucleobase editors
ES2927463T3 (es) 2016-12-09 2022-11-07 Broad Inst Inc Diagnósticos basados en el sistema efector CRISPR
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
TW201839136A (zh) 2017-02-06 2018-11-01 瑞士商諾華公司 治療血色素異常症之組合物及方法
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
JP2020510439A (ja) 2017-03-10 2020-04-09 プレジデント アンド フェローズ オブ ハーバード カレッジ シトシンからグアニンへの塩基編集因子
KR102687373B1 (ko) 2017-03-23 2024-07-23 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
EP3658573A1 (en) 2017-07-28 2020-06-03 President and Fellows of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
WO2019139645A2 (en) 2017-08-30 2019-07-18 President And Fellows Of Harvard College High efficiency base editors comprising gam
CN107727869A (zh) * 2017-10-12 2018-02-23 上海川至生物技术有限公司 一种测定血清中抗核抗体的试剂盒及其制备方法
CN111757937A (zh) 2017-10-16 2020-10-09 布罗德研究所股份有限公司 腺苷碱基编辑器的用途
WO2020127523A1 (en) * 2018-12-20 2020-06-25 Rhodia Operations Polyoxopolyamine desorbents for enhanced oil recovery
WO2020191249A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
MX2022014008A (es) 2020-05-08 2023-02-09 Broad Inst Inc Métodos y composiciones para la edición simultánea de ambas cadenas de una secuencia de nucleótidos de doble cadena objetivo.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5518881A (en) 1993-11-02 1996-05-21 Flinders Medical Centre Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease
US6750052B1 (en) * 1997-07-23 2004-06-15 The Brigham And Women's Hospital, Inc. Lens epithelial cell derived growth factor
CN1439878A (zh) * 2003-01-17 2003-09-03 陕西超英生物医学研究开发有限公司 自身抗体检测组织芯片
JP2008539271A (ja) 2005-04-27 2008-11-13 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーション ｃｓＰＣＮＡイソ型抗体およびその使用
US8168393B2 (en) 2007-02-16 2012-05-01 The Brigham And Women's Hospital, Inc. Compositions and methods for diagnosing tumors using LEDGF/p75
AU2008331381B2 (en) 2007-12-03 2013-08-22 Sqi Diagnostics Systems Inc. Synthetic peptides immuno-reactive with rheumatoid arthritis auto-antibodies
WO2012031122A2 (en) 2010-09-03 2012-03-08 Immport Therapeutics, Inc. Methods and compositions for the diagnosis and treatment of cancer and autoimmune disorders
US9778250B2 (en) 2011-05-10 2017-10-03 The Brigham And Women's Hospital, Inc. Detecting inclusion body myositis
CA2840590C (en) * 2011-07-01 2018-09-04 Inova Diagnostics, Inc. Method for increasing specificity of diagnostic tests for autoimmune diseases
EP2601945A1 (en) 2011-12-05 2013-06-12 Jürgen Thomale Inhibition of cis-platin induced ototoxicity
DK2800811T3 (en) * 2012-05-25 2017-07-17 Univ Vienna METHODS AND COMPOSITIONS FOR RNA DIRECTIVE TARGET DNA MODIFICATION AND FOR RNA DIRECTIVE MODULATION OF TRANSCRIPTION

Also Published As

Publication number Publication date
CA2942347C (en) 2023-03-14
CN112964883A (zh) 2021-06-15
PT3122766T (pt) 2021-05-19
AU2015236327A1 (en) 2016-09-29
AU2019232867A1 (en) 2019-10-10
EP3122766B1 (en) 2021-02-17
WO2015148431A1 (en) 2015-10-01
ES2870592T3 (es) 2021-10-27
AU2021203868A1 (en) 2021-07-22
CN107074927B (zh) 2021-04-02
HUE054419T2 (hu) 2021-09-28
EP3916007A1 (en) 2021-12-01
AU2019232867B2 (en) 2021-03-11
CN107074927A (zh) 2017-08-18
US20200072845A1 (en) 2020-03-05
EP3122766A1 (en) 2017-02-01
EP3122766A4 (en) 2017-08-16
US20170176454A1 (en) 2017-06-22
CA2942347A1 (en) 2015-10-01
US10451633B2 (en) 2019-10-22
AU2015236327B2 (en) 2019-10-10

Similar Documents

Publication Publication Date Title
PT3122766T (pt) Detecção melhorada de anticorpos anti-nucleares e diagnóstico para distúrbios autoimunitários sistémicos e não sistémicos
ZA201700832B (en) Anti-pd-l1 antibodies and diagnostic uses thereof
GB2533936B (en) Flow detection device
HK1209522A1 (en) Device and method for detection
GB2549860B (en) Biomolecule measurement system and biomolecule measurement method
GB201414566D0 (en) Engine State Detection Device
HK1243489A1 (zh) 用於檢測分析物的方法和系統
PL3256341T3 (pl) Urządzenie kontaktowe i zespół szybkiego ładowania
GB2546126B (en) Flow detection device
PT3096784T (pt) Péptidos, dispositivos e métodos para a deteção de anticorpos de anaplasma
GB201709215D0 (en) Evaluation device and evaluation method
GB201619509D0 (en) Sample detection device
EP3238983A4 (en) Seating detection device
GB201409093D0 (en) An immunoassay detection device
GB201421050D0 (en) Load measurement device and method for determining load
GB2518472B (en) Metal-theft detection device
GB201603716D0 (en) Detection device
GB2569469B (en) Flow detection device
IL248458A0 (en) Cry1ca-specific monoclonal antibodies and related detection methods
GB201908101D0 (en) Flow detection device
GB201908100D0 (en) Flow detection device
TWM489700U (en) Volume detection device
GB201600387D0 (en) Detection device
GB201401219D0 (en) Detection device and assay
GB201420898D0 (en) Analyte detection device and method